Published in Blood Weekly, May 8th, 2008
"However, the estrogen receptor (ER) involved in this effect has not yet been characterized. Using recently generated ERalpha-or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.